Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neuroimaging ; 26(2): 201-6, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26011757

RESUMEN

BACKGROUND AND PURPOSE: Amyotrophic Lateral Sclerosis (ALS) is characterized by extensive corticospinal damage, but extrapyramidal involvement is suggested in pathological studies. Texture analysis (TA) is an image processing technique that evaluates the distribution of gray levels between pixels in a given region of interest (ROI). It provides quantitative data and has been employed in several neurodegenerative disorders. Here, we used TA to investigate possible deep gray nuclei (DGN) abnormalities in a cohort of ALS patients. METHODS: Thirty-two ALS patients and 32 healthy controls underwent MRI in a 3T scanner. The T1 volumetric sequence was used for DGN segmentation and extraction of 11 texture parameters using the MaZda software. Statistical analyses were performed using the Mann-Whitney non-parametric test, with a significance level set at α = 0.025 (FDR-corrected) for TA. RESULTS: Patients had significantly higher values for the parameter correlation (CO) in both thalami and in the right caudate nucleus compared to healthy controls. Also, the parameter Inverse Difference Moment or Homogeneity (IDM) presented significantly smaller values in the ALS group in both thalami. CONCLUSIONS: TA of T1 weighted images revealed DGN alterations in patients with ALS, namely in the thalami and caudate nuclei.


Asunto(s)
Esclerosis Amiotrófica Lateral/diagnóstico por imagen , Núcleo Caudado/diagnóstico por imagen , Imagen por Resonancia Magnética/métodos , Tálamo/diagnóstico por imagen , Adulto , Anciano , Esclerosis Amiotrófica Lateral/patología , Núcleo Caudado/patología , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Persona de Mediana Edad , Tálamo/patología
2.
Arq Neuropsiquiatr ; 68(2): 263-8, 2010 04.
Artículo en Inglés | MEDLINE | ID: mdl-20464297

RESUMEN

OBJECTIVE: We evaluated the efficacy of oral supplementation with milk whey proteins and modified starch (70%WPI:30%MS), on nutritional and functional parameters of patients with ALS. METHOD: A prospective randomized double-blind study was performed with 16 ALS patients, divided in two groups, the treatment group received (70%WPI:30%MS) and the control group received (maltodextrin). They underwent prospective nutritional and functional assessment for 4 months. RESULTS: Patients in the treatment group presented weight gain, increased body mass index (BMI), increased arm muscle area and circumference, higher albumin, white blood cell and total lymphocyte counts, and reduced creatine-kinase, aspartate aminotransferase and alanine aminotransferase. In the control group, biochemical parameters did not change, but weight and BMI declined. CONCLUSION: Our results indicate that the agglomerate 70%WPI:30%MS may be useful in the nutritional therapy of patients with ALS.


Asunto(s)
Esclerosis Amiotrófica Lateral/dietoterapia , Suplementos Dietéticos , Proteínas de la Leche/administración & dosificación , Almidón/administración & dosificación , Adulto , Alanina Transaminasa/sangre , Esclerosis Amiotrófica Lateral/enzimología , Aspartato Aminotransferasas/sangre , Creatina Quinasa/sangre , Método Doble Ciego , Femenino , Humanos , Recuento de Linfocitos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Aumento de Peso , Proteína de Suero de Leche
3.
Arq. neuropsiquiatr ; 68(2): 263-268, Apr. 2010. tab
Artículo en Inglés | LILACS | ID: lil-545925

RESUMEN

OBJECTIVE: We evaluated the efficacy of oral supplementation with milk whey proteins and modified starch (70 percentWPI:30 percentMS), on nutritional and functional parameters of patients with ALS. METHOD: A prospective randomized double-blind study was performed with 16 ALS patients, divided in two groups, the treatment group received (70 percentWPI:30 percentMS) and the control group received (maltodextrin). They underwent prospective nutritional and functional assessment for 4 months. RESULTS: Patients in the treatment group presented weight gain, increased body mass index (BMI), increased arm muscle area and circumference, higher albumin, white blood cell and total lymphocyte counts, and reduced creatine-kinase, aspartate aminotransferase and alanine aminotransferase. In the control group, biochemical parameters did not change, but weight and BMI declined. CONCLUSION: Our results indicate that the agglomerate 70 percentWPI:30 percentMS may be useful in the nutritional therapy of patients with ALS.


OBJETIVO: Avaliar a eficácia da suplementação nutricional oral com proteínas do soro do leite e amido modificado (70 por centoWPI:30 por centoMS), nos parâmetros nutricionais e funcionais de pacientes com esclerose lateral amiotrófica (ELA). MÉTODO: Foi realizado estudo randomizado duplo-cego, com 16 pacientes com ELA, divididos em dois grupos, um que recebeu 70 por centoWPI:30 por centoMS e um controle que recebeu maltodextrina. Os pacientes foram submetidos a avaliação nutricional e funcional durante quatro meses. RESULTADOS: Nos pacientes que receberam o suplemento 70 por centoWPI:30 por centoMS, foi observado ganho de peso, aumento na contagem de linfócitos e redução de creatina kinase, aspartato aminotransferase and alanina aminotransferase. No grupo controle, os parâmetros bioquímicos não sofreram modificações; no entanto, peso e índice de massa corporal diminuíram. CONCLUSÃO: Nossos resultados indicam que o aglomerado 70 por centoWPI:30 por centoMS pode ser útil na terapia de pacientes com ALS.


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Esclerosis Amiotrófica Lateral/dietoterapia , Suplementos Dietéticos , Proteínas de la Leche/administración & dosificación , Almidón/administración & dosificación , Alanina Transaminasa/sangre , Esclerosis Amiotrófica Lateral/enzimología , Aspartato Aminotransferasas/sangre , Creatina Quinasa/sangre , Método Doble Ciego , Recuento de Linfocitos , Estudios Prospectivos , Aumento de Peso
4.
Rheumatol Int ; 26(6): 577-80, 2006 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-16328418

RESUMEN

We report a patient with longstanding Behçet disease who presented sudden onset of headache and facial paresis. The magnetic resonance imaging (MRI) showed a mass in the right thalamus, extending to the lentiform nucleus, subthalamic area, right cerebral peduncle and deep subcortical white matter. Stereotactic brain biopsy disclosed gliosis with no signs of malignancy. The diagnosis of a pseudotumoral form of neuro-Behçet disease was done and she was treated with pulse methylpredinisolone and intravenous cyclophosphamide. After 8 weeks she had improved and a new MRI showed disappearance of the tumor-like lesion. The differential diagnosis, especially with central nervous system tumor is emphasized.


Asunto(s)
Síndrome de Behçet/diagnóstico , Encefalopatías/diagnóstico , Adulto , Síndrome de Behçet/tratamiento farmacológico , Encefalopatías/tratamiento farmacológico , Neoplasias Encefálicas/diagnóstico , Neoplasias del Sistema Nervioso Central/diagnóstico , Ciclofosfamida/administración & dosificación , Diagnóstico Diferencial , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Cefalea/fisiopatología , Humanos , Inmunosupresores/administración & dosificación , Inyecciones Intravenosas , Imagen por Resonancia Magnética , Mesencéfalo/patología , Metilprednisolona/administración & dosificación , Quimioterapia por Pulso , Técnicas Estereotáxicas , Tálamo/patología , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA